Ignite Creation Date:
2025-12-24 @ 3:46 PM
Ignite Modification Date:
2025-12-29 @ 4:41 PM
Study NCT ID:
NCT00500292
Status:
COMPLETED
Last Update Posted:
2018-01-25
First Post:
2007-07-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer
Sponsor:
Genzyme, a Sanofi Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D4200C00047
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None